Home › Funds › Arrowstreet Capital › ADPT
Arrowstreet Capital position in ADPT
ADAPTIVE BIOTECHNOLOGIES COR · Health Care
Latest position (Q2 2026)2.52M sh
Reported value held$54.15M
Portfolio Weight0.02%
First reportedQ1 2025
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 45.74K | $339.86K | New |
| Q2 2025 | 379.12K | $4.42M | Add |
| Q3 2025 | 2.44M | $36.52M | Add |
| Q4 2025 | 2.42M | $39.33M | Reduce |
| Q1 2026 | 2.00M | $27.69M | Reduce |
| Q2 2026 | 2.52M | $54.15M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ADPT
- Viking Global Investors 29.99M sh · $643.37M · Q2 2026
- BlackRock Inc 15.14M sh · $324.73M · Q2 2026
- Vanguard Group 11.28M sh · $183.22M · Q4 2025
- Wellington Management Group 5.91M sh · $126.80M · Q2 2026
- D. E. Shaw & Co 4.63M sh · $99.22M · Q2 2026
- Geode Capital Management 3.64M sh · $78.13M · Q2 2026
- UBS Group AG 3.13M sh · $67.15M · Q2 2026
- Invesco Ltd 3.09M sh · $66.37M · Q2 2026
- Goldman Sachs Group 2.98M sh · $64.01M · Q2 2026
- ARK Invest 2.09M sh · $44.84M · Q2 2026
- Bank of America Corp 1.73M sh · $37.11M · Q2 2026